David Szekeres
2021
Compensation breakdown
| Non-Equity Incentive Plan | $197,760 |
|---|---|
| Option Awards | $535,147 |
| Salary | $494,400 |
| Stock Awards | $583,626 |
| Other | $18,498 |
| Total | $1,829,431 |
Szekeres received $583.6K in stock awards, accounting for 32% of the total pay in 2021.
Szekeres also received $197.8K in non-equity incentive plan, $535.1K in option awards, $494.4K in salary and $18.5K in other compensation.
Rankings
In 2021, David Szekeres' compensation ranked 6,385th out of 12,415 executives tracked by ExecPay. In other words, Szekeres earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,385 out of 12,415 | 49th |
Division Manufacturing | 2,726 out of 5,505 | 51st |
Major group Chemicals And Allied Products | 1,200 out of 2,375 | 50th |
Industry group Drugs | 1,068 out of 2,096 | 49th |
Industry Pharmaceutical Preparations | 771 out of 1,546 | 50th |
Pay ratio
| David Szekeres' Pay | $1,829,431 |
|---|---|
| Median Employee's Pay | $268,692 |
| Pay Ratio | 7to 1 |
In 2021, the annual total compensation of David Szekeres was $1,829,431.
The annual total compensation of the median employee at Heron Therapeutics was $268,692.
The ratio of David Szekeres' pay to the pay of median employee was therefore 7 to one.
Szekeres' colleagues
We found four more compensation records of executives who worked with David Szekeres at Heron Therapeutics in 2021.
News
April 29, 2024
May 1, 2023
April 25, 2022
April 22, 2021